(Q41984773)

14 October 2017

Combined therapies that induce senescence and stabilize p53 block melanoma growth and prompt antitumor immune responses (English)

1 reference

14 October 2017

2

Ann Richmond

1 reference

14 October 2017

Anna Vilgelm

1

1 reference

14 October 2017

19 March 2015

1 reference

14 October 2017

1 reference

14 October 2017

4

1 reference

14 October 2017

8

1 reference

14 October 2017

e1009299

1 reference

Mdm2 and aurora kinase a inhibitors synergize to block melanoma growth by driving apoptosis and immune clearance of tumor cells

14 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4570092

5 June 2018

Senescence at a glance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4570092

Targeting aurora kinases limits tumour growth through DNA damage-mediated senescence and blockade of NF-κB impairs this drug-induced senescence.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4570092

Four faces of cellular senescence.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4570092

Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4570092

Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4570092

Restoration of p53 function leads to tumour regression in vivo

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4570092

Reversal of human cellular senescence: roles of the p53 and p16 pathways

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4570092

Polyploidy road to therapy-induced cellular senescence and escape.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4570092

A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy

18 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26405565

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1080/2162402X.2015.1009299

1 reference

14 October 2017

1 reference

PMC publication ID

4570092

14 October 2017

PubMed publication ID

26405565

1 reference

PMC publication ID

4570092